JP2016539148A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539148A5 JP2016539148A5 JP2016536528A JP2016536528A JP2016539148A5 JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5 JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- optionally substituted
- phenyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1CC2(CC2)C(*)CC1 Chemical compound *C1CC2(CC2)C(*)CC1 0.000 description 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13195720.1 | 2013-12-04 | ||
| EP13195720 | 2013-12-04 | ||
| PCT/EP2014/075890 WO2015082324A1 (en) | 2013-12-04 | 2014-11-28 | Sulfoximine substituted quinazolines for pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539148A JP2016539148A (ja) | 2016-12-15 |
| JP2016539148A5 true JP2016539148A5 (enExample) | 2017-11-30 |
| JP6457523B2 JP6457523B2 (ja) | 2019-01-23 |
Family
ID=49726564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016536528A Expired - Fee Related JP6457523B2 (ja) | 2013-12-04 | 2014-11-28 | 医薬組成物のためのスルホキシイミン置換キナゾリン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10093660B2 (enExample) |
| EP (1) | EP3077383B1 (enExample) |
| JP (1) | JP6457523B2 (enExample) |
| AU (1) | AU2014359456B2 (enExample) |
| CA (1) | CA2929742C (enExample) |
| ES (1) | ES2693520T3 (enExample) |
| WO (1) | WO2015082324A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6479854B2 (ja) * | 2014-05-07 | 2019-03-06 | エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＥｖｏｔｅｃ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ | 医薬組成物のためのスルホキシイミン置換キナゾリン |
| AR117788A1 (es) * | 2019-01-14 | 2021-08-25 | Pi Industries Ltd | Compuestos de fenilamidina 3-sustituida, preparación y uso |
| CN112812136B (zh) * | 2019-11-15 | 2022-04-12 | 武汉光谷亚太医药研究院有限公司 | 新型2,3-二氢化茚衍生化合物、制备方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3987192A (en) | 1974-01-07 | 1976-10-19 | The Upjohn Company | Compositions and process of treatment |
| US5602118A (en) | 1993-03-16 | 1997-02-11 | American Cyanamid Company | 2-thiosubstituted carbapenems |
| CA2188772A1 (en) | 1994-06-08 | 1995-12-14 | Balreddy Kamireddy | Cyclic sulfonamide herbicides |
| SE0102147D0 (sv) | 2001-06-18 | 2001-06-18 | Pharmacia Ab | New methods |
| AU2002363175A1 (en) | 2001-10-29 | 2003-05-12 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| MXPA04008403A (es) | 2002-03-01 | 2004-11-26 | Pfizer | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso. |
| GB0315587D0 (en) | 2003-07-03 | 2003-08-13 | Univ Dundee | Anti-inflammatory assay and compounds |
| CN101648906B (zh) | 2004-04-08 | 2012-07-11 | 美国陶氏益农公司 | 杀虫用n-取代亚磺酰亚胺 |
| EP1746099A1 (en) | 2004-12-23 | 2007-01-24 | DeveloGen Aktiengesellschaft | Mnk1 or Mnk2 inhibitors |
| AU2006261082B2 (en) * | 2005-06-22 | 2012-04-19 | Boehringer Ingelheim International Gmbh | Thienopyrimidines for pharmaceutical compositions |
| EP1991547A2 (en) | 2006-03-09 | 2008-11-19 | Pharmacopeia, Inc. | 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| CA2651898A1 (en) | 2006-04-07 | 2007-10-18 | Develogen Aktiengesellschaft | Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| DE602007004618D1 (de) | 2006-06-22 | 2010-03-18 | Biovitrum Ab Publ | Pyridin- und pyrazinderivate als mnk-kinaseinhibitoren |
| DE102007024470A1 (de) | 2007-05-24 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren |
| US8003787B2 (en) * | 2007-05-24 | 2011-08-23 | Bayer Schering Pharma Ag | Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| JP2011510033A (ja) | 2008-01-25 | 2011-03-31 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 化合物 |
| WO2011062885A1 (en) | 2009-11-23 | 2011-05-26 | Schering Corporation | Fused bicyclic pyrimidine derivatives and methods of use thereof |
| UY33241A (es) * | 2010-02-26 | 2011-09-30 | Boehringer Ingelheim Int | ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?. |
| ES2562959T3 (es) | 2010-02-26 | 2016-03-09 | Evotec International Gmbh | Tienopirimidinas que contienen un grupo alquilo sustituido para composiciones farmacéuticas |
| AR088082A1 (es) | 2011-10-13 | 2014-05-07 | Lilly Co Eli | Moduladores selectivos del receptor androgeno |
| JP6306035B2 (ja) * | 2012-11-09 | 2018-04-04 | エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＥｖｏｔｅｃ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ | 医薬組成物のためのスルホキシミン置換キナゾリン |
| AU2014301295C1 (en) * | 2013-06-28 | 2018-03-15 | Evotec International Gmbh | Sulfoximine substituted quinazolines and their use as MNK1 and/or MNK2 kinase inhibitors |
-
2014
- 2014-11-28 US US15/101,620 patent/US10093660B2/en active Active
- 2014-11-28 CA CA2929742A patent/CA2929742C/en active Active
- 2014-11-28 EP EP14808895.8A patent/EP3077383B1/en active Active
- 2014-11-28 ES ES14808895.8T patent/ES2693520T3/es active Active
- 2014-11-28 JP JP2016536528A patent/JP6457523B2/ja not_active Expired - Fee Related
- 2014-11-28 AU AU2014359456A patent/AU2014359456B2/en not_active Ceased
- 2014-11-28 WO PCT/EP2014/075890 patent/WO2015082324A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016515561A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2014532647A5 (enExample) | ||
| JP2015511609A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2014528464A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| RU2016141569A (ru) | Комбинации | |
| JP2017517538A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| HK1210771A1 (zh) | 氮杂吲哚衍生物 | |
| JP2015509075A5 (enExample) | ||
| JP2017518360A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| JP2012522841A5 (enExample) | ||
| JP2018525425A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| JP2016515550A5 (enExample) | ||
| BR112015016184A2 (pt) | derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
| JP2021503451A5 (enExample) | ||
| RU2018117499A (ru) | Производные 6-[5-амино-6-(2-этоксиэтокси)-имидазо[4,5-b]пиридин-3-ил]никотинонитрила и их применение в качестве irak ингибиторов |